US appeals court revives private lawsuits linking Tylenol to autism [View all]
Source: USA Today/Reuters
July 13, 2026, 11:32 a.m. ET
NEW YORK, July 13 (Reuters) - A federal appeals court on Monday revived more than 500 private lawsuits against Tylenol maker Kenvue over the painkiller's alleged link to autism.
The 2nd U.S. Circuit Court of Appeals in Manhattan said a district court judge improperly excluded testimony from expert witnesses offered by parents and guardians who tied Tylenol use during pregnancy to autism and attention deficit hyperactivity disorder in children.
There is no firm scientific evidence of such a link. The issue drew greater attention after President Donald Trump and top U.S. health officials in September suggested a link to autism. Kenvue did not immediately respond to a request for comment. Its shares traded down 10 cents at $19.38 in morning trading.
Monday's decision followed Kenvue's agreement last November to be acquired by Kleenex tissue maker Kimberly-Clark for more than $40 billion.
Read more: https://www.usatoday.com/story/news/politics/2026/07/13/lawsuits-lin-tylenol-to-autism/90901305007/
Link to
ORDER (PDF) - -
https://ww3.ca2.uscourts.gov/decisions/OPN/24-916_24-2594_redacted_opn.pdf
This was unanimous by a Clintonn judge, an Obama judge and a Biden judge. It was more of a technical objection to excluding some expert witnesses and is remanded back to the lower court.